FedBizOpps banner

Login to begin searching the FBO/CBD
Home Page
CBD/FBO Online
CBD/FBO Email
About Us
Contact Us
Privacy
Categories
No. Notes
Archives
Search
Help
Login
Register

Popular Searches

Popular Categories

Specimen Collection Contract for Pueblo Chemical Depot - Additional information to offerors

General Information

Document Type:PRESOL
Posted Date:Sep 07, 2017
Category: Medical Services
Set Aside:N/A

Contracting Office Address

Department of the Army, Army Contracting Command, ACC - APG (W9125F) Denver, 72ND AND QUEBEC STREET KO, COMMERCE CITY, Colorado, 80022-1748, United States

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. Performance Work Statement for Collection Contract Pueblo Chemical Depot The Contractor shall provide all necessary personnel, and supervision for the collection, security, temporary storage and delivery of urine specimens to the Installation Drug Testing Program Collection Point (DTPCP) at Pueblo Chemical Depot (PCD), Building 5. Normal hours of operation are Monday through Thursday, 6:30 AM to 5:00 PM. Notification to the contractor for collection shall be 24 hours in advance. Contractor personnel shall be designated as the collection site personnel. A collection site person shall have successfully completed training to carry out this function and be a Department of Transportation certified collection professional in accordance with DOT Federal Register Part 40.33 and be trained and certified as a Breath Alcohol Technician proficient in 49 CFR Part 40 procedures. A collection site will be designated by the installation. A designated collection site will have an enclosure within which private urination can occur, a toilet for completion of urination and a suitable clean surface for writing. The site will also have a source of water for washing hands, which, if possible, will be external to the enclosure where urination occurs. Security during collection shall be maintained by restriction of access to collection materials and specimens. When a public rest room is used, the facility must be posted against access during the entire collection procedure to avoid embarrassment to the employee or distraction of the collection site person. No unauthorized personnel shall be permitted in any part of the designated collection site where urine specimens are collected or stored. Only the collection site person may handle specimens prior to their securement in the mailing container or monitor or observe specimen collection. The collection site person shall have only one donor under his or her supervision at any time. A collection procedure is complete when the urine bottle has been sealed and initialed, the drug testing custody and control form has been executed, and the employee has departed the site (or, in the case of an employee who was unable to provide a complete specimen, has entered a waiting area). The collection site person shall take precautions to ensure that a urine specimen is not adulterated or diluted during the collection procedure and that information on the urine bottle and on the urine custody and control form can identify the employee from whom the specimen was collected. The collection site person shall note any unusual behavior or appearance on the urine custody and control form. The following minimum precautions shall be taken to ensure that unadulterated specimens are obtained and correctly identified: To deter the dilution of specimens at the collection site, toilet-bluing agents shall be placed in toilet tanks or bowls so the reservoir of water in the toilet bowl always remains blue. Where practicable, there shall be no other source of water (e.g., shower or sink) in the enclosure where urination occurs. If there is another source of water in the enclosure it shall be effectively secured or monitored to ensure it is not used as a source for diluting the specimen. When an employee arrives at the collection site, the collection site person shall ensure that the employee is positively identified as the employee selected for testing (e.g., through presentation of photo identification or identification by the employers representative). If the employees identity cannot be established, the collection site person shall not proceed with the collection. If the employee fails to arrive at the assigned time, the collection site person shall contact the appropriate installation authority to obtain guidance on the action to be taken. The collection site person shall ask the employee to remove any unnecessary outer garments such as a coat or jacket that might conceal items or substances that could be used to tamper with or adulterate the employees urine specimen. The collection site person shall ensure that all personal belongings such as a purse or briefcase remain with the outer garments. The employee shall be instructed to wash and dry his or her hands prior to urination. After washing hands, the employee shall remain in the presence of the collection site person and shall not have access to any water fountain, faucet, soap dispenser, cleaning agent or any other materials that could be used to adulterate the specimen. The employee may provide his/her specimen in the privacy of a stall or otherwise partitioned area that allows for employee privacy. The collection site person shall provide the employee with a specimen bottle or collection container. A clean, single-use collection container (e.g., disposable cup or sterile urinal) or specimen bottle that is securely wrapped until used may be employed. If urination is directly into the specimen bottle, the specimen bottle shall be provided to the employee still sealed in its wrapper or shall be unwrapped in the employees presence immediately prior to its being provided. If a separate collection container is used for urination, the collection container shall be provided to the employee still sealed in its wrapper or shall be unwrapped in the employees presence immediately prior to its being provided; and the collection site person shall unwrap the specimen bottle in the presence of the employee at the time the urine specimen is presented. The specimen bottle shall be identified with a unique identifying number identical to that appearing on the urine custody and control form, and space shall be provided to initial the bottle affirming its identity. The collection site person shall instruct the employee to provide at least 45 ml of urine using the split sample method of collection. The split sample method of collection shall follow the following procedures: The donor shall urinate into a collection container or a specimen bottle capable of holding at least 60 ml. If a collection container is used, the collection site person, in the presence of the donor, pours the urine into two specimen bottles. Thirty- (30) ml shall be poured into one specimen bottle, to be used as the primary specimen. At least 15 ml shall be poured into the other bottle, to be used as the split specimen. Both bottles shall be shipped in a single shipping container, together with copy 1 of the chain of custody form, to the laboratory. If the employee has not provided the required quantity of urine, the specimen shall be discarded. The collection site person shall direct the employee to drink up to 40 ounces of fluid, distributed reasonably through a period of up to three hours, or until the employee has provided a new urine specimen, whichever comes first. If the employee refuses to drink fluids as directed or to provide a new urine specimen, the collection site person shall terminate the collection and notify the installation POC that the employee has refused to submit to testing. If the employee has not provided a sufficient specimen within three hours of the first unsuccessful attempt to provide the specimen, the collection site person shall discontinue the collection and notify the installation POC. After the specimen has been provided and submitted to the collection site person, the employee shall be allowed to wash his or her hands. Immediately after the specimen is collected, the collection site person shall measure the temperature of the specimen. The temperature-measuring device used must accurately reflect the temperature of the specimen and not contaminate the specimen. The time from urination to temperature measure is critical and in no case shall exceed 4 minutes. A specimen temperature outside the range of 32° - 38° C/90°- 100° F constitutes a reason to believe that the employee has altered or substituted the specimen. In such cases, the employee supplying the specimen may volunteer to have his or her oral temperature taken to provide evidence to counter the reason to believe the employee may have altered or substituted the specimen. Immediately after the specimen is collected, the collection site person shall also inspect the specimen to determine its color and look for any signs of contaminants. Any unusual findings shall be noted on the urine custody and control form. All specimens suspected of being adulterated shall be forwarded to the laboratory for testing. Both the employee being tested and the collection site person shall keep the specimen in view at all times prior to its being sealed and labeled. The specimen shall be sealed (by placement of a tamper proof seal over the bottle cap and down the sides of the bottle) and labeled in the presence of the employee. If the specimen is transferred to a second bottle, the collection site person shall request the employee to observe the transfer of the specimen and the placement of the tamper proof seal over the bottle cap and down the sides of the bottle. The collection site person shall place securely on the bottle an identification label that contains the date, the employees specimen number, and any other identifying information required. The employee shall initial the identification label on the specimen bottle for the purpose of certifying that it is the specimen collected from him or her. The collection site person shall enter on the drug testing custody and control form all information identifying the specimen. The collection site person shall sign the drug testing custody and control form certifying that the collection was accomplished according to the applicable Federal requirements. The employee shall be asked to read and sign a statement on the drug testing custody and control form certifying that the specimen identified as having been collected from him or her is in fact the specimen he or she provided. The collection site person shall complete the chain of custody portion of the drug testing custody and control form to indicate receipt of the specimen from the employee and shall certify proper completion of the collection. If the specimen is not immediately prepared for shipment, the collection site person shall ensure that it is appropriately safeguarded during temporary storage. While any part of the above chain of custody procedures is being performed, it is essential that the urine specimen and custody documents be under the control of the collection site person. The collection site person shall not leave the collection site in the interval between presentation of the specimen by the employee and securement of the sample with an identifying label bearing the employees specimen identification number (shown on the urine custody and control form) and seal initialed by the employee. If it becomes necessary for the collection site person to leave the site during this interval, the collection shall be nullified and (at the election of the installation POC) a new collection begun. Collection site personnel shall keep the employees specimen bottle within sight both before and after the employee has urinated. After the specimen is collected, it shall be properly sealed and labeled. All collection and handling of urine during the collection process as described above will be in accordance with Health and Human Services Mandatory Guidelines. The installation POC is responsible for supplying the names of those to be tested, shipping the specimens to the laboratory for testing and maintaining records pertaining to the testing process. Breath alcohol testing will be conducted according to DOT 49 CFR Part 40 procedures. DEFINITIONS: Canceled or invalid test. In drug testing, a drug test that has been declared invalid by a Medical Review Officer. A canceled test is neither a positive nor a negative test. For purposes of this part, a sample that has been rejected for testing by a laboratory is treated the same as a canceled test. It is neither a positive nor a negative test. Chain of custody. Procedures to account for the integrity of each urine or blood specimen by tracking its handling and storage from point of specimen collection to final disposition of the specimen. These procedures shall require that an appropriate drug testing custody form be used from time of collection to receipt by the laboratory and that upon receipt by the laboratory an appropriate laboratory chain of custody form(s) account(s) for the sample or sample aliquots within the laboratory. Collection container. A container into which the employee urinates to provide the urine sample used for a drug test. Collection site. A place designated by the employer where employees present themselves for the purpose of providing a specimen of their urine to be analyzed for the presence of drugs. Collection site person. A person who instructs and assists employees at a collection site and who receives and makes a screening examination of the urine specimen provided by those employees. Employee. An individual that is subject to drug testing. Employee may include an applicant for employment. Installation POC. Installation point of contact. The installation person responsible for the drug testing program, random selection process and record keeping. Medical Review Officer (MRO). A licensed physician (medical doctor or doctor of osteopathy) responsible for receiving laboratory results generated by an employers drug testing program who has knowledge of substance abuse disorders and has appropriate medical training to interpret and evaluate an employees confirmed positive test result together with his or her medical history and any other relevant biomedical information. Screening test (or initial test). In drug testing, immunoassays screen to eliminate ``negative urine specimens from further analysis. In alcohol testing, an analytic procedure to determine whether an employee may have a prohibited concentration of alcohol in a breath specimen. Shipping container. A container capable of being secured with a tamper-evident seal that is used for transfer of one or more urine specimen bottle(s) and associated documentation from the collection site to the laboratory. Specimen bottle. The bottle that, after being labeled and sealed according to the procedures in this part, is used to transmit urine sample to the laboratory. Substance abuse professional. A licensed physician (Medical Doctor or Doctor of Osteopathy); or a licensed or certified psychologist, social worker, or employee assistance professional; or an addiction counselor (certified by the National Association of Alcoholism and Drug Abuse Counselors Certification Commission or by the International Certification Reciprocity Consortium/Alcohol & Other Drug Abuse). All must have knowledge of and clinical experience in the diagnosis and treatment of alcohol and controlled substances-related disorders. Special Instructions: 1. Access and General Protection/Security Policy and Procedures: The contractor maintain a current law enforcement background check for each employee including subcontractor employees, requiring access to Army installations, facilities, or controlled access areas shall complete prior to the employee arriving at PCD. The law enforcement background check shall not be older than 30 days and is only valid for one year. Documentation of these checks shall be made available to the KO and COR. Seven days prior to entrance to an Army-controlled installation or facility the contractor shall provide the names of all contractor employees to include subcontractor to the COR. PCD Policy 19 Foreign Discloser Program will be followed for Non-US Citizens. The contractor shall ensure that its employees entering Army-controlled installations or facilities have obtained access badges and passes in accordance with facility regulations and that these badges and passes are obtained in advance so as not to delay the accomplishment of contracted services. The contractor shall return all issued U.S. Government Common Access Cards, installation badges, and/or access passes to the Chief, Security and Access Control or designated Government representative upon request, when the contract is completed or when a contractor employee no longer requires access to the installation or facility. If a contractor or subcontractor is issued vehicle placard the placard shall be removed from the window prior to leaving the installation. Force Protection Condition (FPCON) Impact on Work Levels: In the event the FPCON Level is elevated to Charlie the installation shall evaluate the need for contract services to be discontinued. At FPCON Delta, services are discontinued. Services shall resume when the FPCON level has been lowered Antiterrorism (AT) Level I Training: This provision/contract text is for contractor employees with an area of performance within an Army-controlled installation, facility, or area. All contractor employees, including subcontractor employees, requiring access to Army installations, facilities, or controlled access areas shall complete AT Level I awareness training within thirty calendar days of contract award, within fourteen calendar days of new employees commencing performance, and fourteen calendar days of contract being renewed, with the results reported to the COR no later than seven calendar days after contract award. The contractor shall submit certificates of completion for each affected contractor employee and subcontractor employee to the COR (or to the contracting officer, if a COR is not assigned) within seven calendar days after completion of training by all employees and subcontractor personnel. AT Level I awareness training is available at https://atlevel1.dtic.mil/at. iWATCH Training: This provision/contract text is for contractor employees with an area of performance within an Army-controlled installation, facility, or area. The contractor and all associated subcontractors shall brief all employees on the local iWATCH program (training standards provided by the requiring activity ATO). This locally developed training shall be used to inform employees of the types of behavior to watch for and instruct employees to report suspicious activity to the COR. This training shall be completed within fourteen calendar days of contract award and within seven calendar days of new employees commencing performance, and fourteen calendar days of contract being renewed, with the results reported to the COR no later than seven calendar days after contract award. OPSEC: Contractors are not authorized to release any information (including observations, written and oral correspondence, photography, maps and drawings) obtained while working on PCD directly to the public. All information must undergo a security review by a PCD Operations Security (OPSEC) Officer and be approved for release to the public from PCDs Public Affairs Officer.

Original Point of Contact

POC Hugh P. Blaney, Phone: 3032890149

Place of Performance

Address:
Pueblo Chemical Depo, 45825 Highway 96 East, Pueblo, Colorado, 81006, United States
81006,
Link: FBO.gov Permalink
Bookmark This Notice
Print View